Condition
Pediatric-Onset Multiple Sclerosis (POMS)
Total Trials
4
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
1 of 0 completed with results
Key Signals
1 with results0
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 2 (1)
Trial Status
Not Yet Recruiting2
Recruiting1
Terminated1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07571304Not ApplicableRecruitingPrimary
Dual-Task Training in Pediatric Multiple Sclerosis
NCT07257900Not ApplicableNot Yet RecruitingPrimary
Comparison of Structured Exercise and Exergaming in Pediatric-Onset Multiple Sclerosis
NCT05000216Phase 2Terminated
COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders
NCT06648499Not Yet RecruitingPrimary
Five Times Sit-To-Stand Test for Patients with Pediatric-Onset Multiple Sclerosis
Showing all 4 trials